Published in Dtsch Arztebl Int on February 13, 2009
Food allergy in adults: an over- or underrated problem? Dtsch Arztebl Int (2008) 1.50
Histamine down-regulates IL-27 production in antigen-presenting cells. J Leukoc Biol (2012) 3.12
Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nat Med (2005) 2.92
Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology-European Academy of Allergy and Clinical Immunology PRACTALL consensus report. J Allergy Clin Immunol (2012) 2.90
Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme. N Engl J Med (2015) 2.44
Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol (2006) 2.09
Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol (2006) 2.00
Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol (2007) 1.87
Interleukin-17A promotes IgE production in human B cells. J Invest Dermatol (2010) 1.79
Human inflammatory dendritic epidermal cells express a functional histamine H4 receptor. J Invest Dermatol (2008) 1.73
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid. Arch Dermatol (2007) 1.59
Histamine upregulates keratinocyte MMP-9 production via the histamine H1 receptor. J Invest Dermatol (2008) 1.58
Human keratinocytes express AIM2 and respond to dsDNA with IL-1β secretion. Exp Dermatol (2011) 1.53
The German Multicentre Study on Multiple Chemical Sensitivity (MCS). Int J Hyg Environ Health (2008) 1.45
2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol (2012) 1.36
The toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J Allergy Clin Immunol (2004) 1.35
World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base. Int Arch Allergy Immunol (2013) 1.31
Correlation of IL-31 serum levels with severity of atopic dermatitis. J Allergy Clin Immunol (2008) 1.28
Histamine H4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells. J Immunol (2005) 1.27
1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. Eur J Immunol (2008) 1.25
Variants in a novel epidermal collagen gene (COL29A1) are associated with atopic dermatitis. PLoS Biol (2007) 1.21
Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis. J Allergy Clin Immunol (2011) 1.15
Effect of sildenafil on digital ulcers in systemic sclerosis: analysis from a single centre pilot study. Ann Rheum Dis (2009) 1.13
High-density genotyping study identifies four new susceptibility loci for atopic dermatitis. Nat Genet (2013) 1.11
Investigation of contact allergy to dental metals in 206 patients. Contact Dermatitis (2009) 1.10
Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features. Arthritis Res Ther (2011) 1.09
Human keratinocytes respond to interleukin-18: implication for the course of chronic inflammatory skin diseases. J Invest Dermatol (2005) 1.07
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus. Arch Dermatol (2006) 1.06
Implementation of anaphylaxis management guidelines: a register-based study. PLoS One (2012) 1.05
Provoking allergens and treatment of anaphylaxis in children and adolescents--data from the anaphylaxis registry of German-speaking countries. Pediatr Allergy Immunol (2011) 1.04
The Toll-like receptor 2 R753Q mutation modifies cytokine production and Toll-like receptor expression in atopic dermatitis. J Allergy Clin Immunol (2008) 1.03
[AWMF Guideline no. 013/066. Diagnosis and therapy of circumscribed scleroderma]. J Dtsch Dermatol Ges (2009) 1.02
The histamine H4 receptor is functionally expressed on T(H)2 cells. J Allergy Clin Immunol (2009) 1.01
Clopidogrel-associated angioedema. Am J Med (2003) 1.01
IL-13-stimulated human keratinocytes preferentially attract CD4+CCR4+ T cells: possible role in atopic dermatitis. J Invest Dermatol (2006) 1.00
Induction of long-lived allergen-specific plasma cells by mucosal allergen challenge. J Allergy Clin Immunol (2009) 1.00
Histamine H4 receptor antagonism reduces hapten-induced scratching behaviour but not inflammation. Exp Dermatol (2008) 0.99
Malassezia sympodialis thioredoxin-specific T cells are highly cross-reactive to human thioredoxin in atopic dermatitis. J Allergy Clin Immunol (2011) 0.98
Linking allergy to autoimmune disease. Trends Immunol (2009) 0.97
Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clin Transl Allergy (2012) 0.97
Histamine downregulates monocyte CCL2 production through the histamine H4 receptor. J Allergy Clin Immunol (2007) 0.96
Immunoglobulin E-reactivity of wheat-allergic subjects (baker's asthma, food allergy, wheat-dependent, exercise-induced anaphylaxis) to wheat protein fractions with different solubility and digestibility. Mol Nutr Food Res (2004) 0.94
1alpha,25-dihydroxyvitamin D3 inhibits anti-CD40 plus IL-4-mediated IgE production in vitro. Eur J Immunol (2002) 0.94
Staphylococcal alpha-toxin is a strong inducer of interleukin-17 in humans. Infect Immun (2011) 0.94
Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis. Arthritis Res Ther (2014) 0.94
Safety of a rush immunotherapy build-up schedule with depigmented polymerized allergen extracts. Allergy Asthma Proc (2010) 0.93
Modulation of keratinocyte-derived MMP-9 by IL-13: a possible role for the pathogenesis of epidermal inflammation. J Invest Dermatol (2007) 0.93
Epicutaneous allergen administration: a novel approach for allergen-specific immunotherapy? J Allergy Clin Immunol (2009) 0.93
Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule. J Clin Oncol (2002) 0.93
Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis. Dermatology (2004) 0.93
Treatment of atopic dermatitis with pimecrolimus - impact on quality of life. Ther Clin Risk Manag (2007) 0.92
Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a. J Invest Dermatol (2006) 0.91
Structured education program improves the coping with atopic dermatitis in children and their parents-a multicenter, randomized controlled trial. J Psychosom Res (2009) 0.91
Introducing genetic testing for adult-type hypolactasia. Digestion (2005) 0.91
Human monocyte-derived dendritic cells are chemoattracted to C3a after up-regulation of the C3a receptor with interferons. Immunology (2004) 0.91
Staphylococcal exotoxins are strong inducers of IL-22: A potential role in atopic dermatitis. J Allergy Clin Immunol (2010) 0.91
Increased sensitivity of patch testing by standardized tape stripping beforehand: a multicentre diagnostic accuracy study. Contact Dermatitis (2010) 0.91
Cooking birch pollen-related food: divergent consequences for IgE- and T cell-mediated reactivity in vitro and in vivo. J Allergy Clin Immunol (2006) 0.90
Evidence for a pathogenetic role of interleukin-18 in cutaneous lupus erythematosus. Arthritis Rheum (2008) 0.90
Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis. Am J Clin Dermatol (2005) 0.89
Systemic PPARgamma ligation inhibits allergic immune response in the skin. J Invest Dermatol (2008) 0.89
Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis? J Allergy Clin Immunol (2006) 0.89
Evidence for a regulatory loop between IFN-γ and IL-33 in skin inflammation. Exp Dermatol (2013) 0.89
Rapid identification and differentiation of fungal DNA in dermatological specimens by LightCycler PCR. J Med Microbiol (2004) 0.89
Staphylococcus aureus-derived enterotoxins enhance house dust mite-induced patch test reactions in atopic dermatitis. Exp Dermatol (2007) 0.88
Analysis of the composition of an immunoglobulin E reactive high molecular weight protein complex of peanut extract containing Ara h 1 and Ara h 3/4. Proteomics (2005) 0.88
Antibiotic treatment of cutaneous infections with Staphylococcus aureus in patients with atopic dermatitis: current antimicrobial resistances and susceptibilities. Exp Dermatol (2008) 0.88
Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis. J Allergy Clin Immunol (2012) 0.88
Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: a two-year study. J Am Acad Dermatol (2005) 0.88
RAC1 in keratinocytes regulates crosstalk to immune cells by Arp2/3-dependent control of STAT1. J Cell Sci (2012) 0.88
Suppression of IL-12 production by soluble CD40 ligand: evidence for involvement of the p44/42 mitogen-activated protein kinase pathway. J Immunol (2002) 0.88
Role of macrophages in the pathogenesis of atopic dermatitis. Mediators Inflamm (2013) 0.88
Isolation and characterization of natural Ara h 6: evidence for a further peanut allergen with putative clinical relevance based on resistance to pepsin digestion and heat. Mol Nutr Food Res (2004) 0.87
The histamine H4 receptor is highly expressed on plasmacytoid dendritic cells in psoriasis and histamine regulates their cytokine production and migration. J Invest Dermatol (2011) 0.87
Skin testing with food allergens. Guideline of the German Society of Allergology and Clinical Immunology (DGAKI), the Physicians' Association of German Allergologists (ADA) and the Society of Pediatric Allergology (GPA) together with the Swiss Society of Allergology. J Dtsch Dermatol Ges (2008) 0.87
Pharmacological characterization of the new histamine H4 receptor agonist VUF 8430. Br J Pharmacol (2009) 0.87
A protective role of complement component 3 in T cell-mediated skin inflammation. Exp Dermatol (2011) 0.87
IL-27 Regulates IL-18 binding protein in skin resident cells. PLoS One (2012) 0.87
Expression and function of histamine receptors 1 and 2 on human monocyte-derived dendritic cells. J Allergy Clin Immunol (2002) 0.87
Vitamin D receptor binds to the ε germline gene promoter and exhibits transrepressive activity. J Allergy Clin Immunol (2010) 0.86
Guideline on the management of hand eczema ICD-10 Code: L20. L23. L24. L25. L30. J Dtsch Dermatol Ges (2009) 0.86
Innate immunity, allergy and atopic dermatitis. Curr Opin Allergy Clin Immunol (2010) 0.86
Human dendritic cells express the IL-18R and are chemoattracted to IL-18. J Immunol (2003) 0.86
[Atopic dermatitis: S2 guidelines]. J Dtsch Dermatol Ges (2009) 0.86
Role of adverse reactions to food in urticaria and exercise-induced anaphylaxis. Int Arch Allergy Immunol (2002) 0.86
Primary human keratinocytes efficiently induce IL-1-dependent IL-17 in CCR6+ T cells. Exp Dermatol (2010) 0.86
Vitamin D receptor activation improves allergen-triggered eczema in mice. J Invest Dermatol (2011) 0.86
Allergy prevention. Dtsch Arztebl Int (2009) 0.85
Inhibition of IgE production by docosahexaenoic acid is mediated by direct interference with STAT6 and NFκB pathway in human B cells. J Nutr Biochem (2010) 0.85
A nematode immunomodulator suppresses grass pollen-specific allergic responses by controlling excessive Th2 inflammation. Int J Parasitol (2012) 0.85
Cabbage allergy: a rare cause of food-induced anaphylaxis. Acta Derm Venereol (2013) 0.85
The placebo effect in allergen-specific immunotherapy trials. Clin Transl Allergy (2013) 0.85
Liver X receptors control IgE expression in B cells. J Immunol (2009) 0.85
Staphylococcal α-toxin induces a higher T cell proliferation and interleukin-31 in atopic dermatitis. Int Arch Allergy Immunol (2011) 0.85
Difficult to control atopic dermatitis. World Allergy Organ J (2013) 0.84
Development of alopecia areata universalis in a patient receiving adalimumab. Arch Dermatol (2006) 0.84